We provide comprehensive profiling from laboratory-scale pilot studies to high-throughput industrial screening, utilizing spatial transcriptomics and proteomics to map the molecular landscape across various scales of drug discovery projects.
Creative Biolabs provides a comprehensive analytical platform for the simultaneous profiling of cancer stem cells (CSCs), Hypoxia, and CAFs. We provide integrated 3D co-culture modeling, spatial transcriptomics, and metabolic flux analysis to decode the survival mechanisms of malignant cells. By partnering with us, our clients expect to gain deep mechanistic insights into niche-mediated resistance, identify synergistic target combinations, and validate lead compounds in high-fidelity environments that closely mirror in vivo tumor biology.
The tumor microenvironment is a master regulator of therapy resistance. Scientific literature highlights that hypoxia stabilizes specific transcription factors, which directly transactivate stemness markers and Notch signaling, driving CSC self-renewal. Simultaneously, CAFs undergo metabolic reprogramming, providing fuels that protect CSCs. Our service synthesizes these complex mechanisms into a single, actionable profiling platform. By integrating advanced breakthroughs in mechanotransduction and metabolic symbiosis, Creative Biolabs provides the credibility and data depth required to overcome the "Triple Threat" of tumor biology.
Fig.1 CAF-mediated cancer progression in hypoxia. 1
We provide comprehensive profiling from laboratory-scale pilot studies to high-throughput industrial screening, utilizing spatial transcriptomics and proteomics to map the molecular landscape across various scales of drug discovery projects.
Our specialized hypoxic chambers utilize advanced process analytical techniques (PAT) to maintain strict atmospheric stability, ensuring that oxygen-sensitive signaling pathways and metabolic responses remain consistent and reproducible.
We utilize verified cell bank systems to safeguard the genetic and phenotypic stability of CSCs and CAFs, supporting high-quality results during extensive large-scale culturing and critical pre-cultivation phases.
Our team optimizes codon usage for reporter genes to enhance expression levels, facilitating high-sensitivity tracking of stemness markers and signaling dynamics within the specific constraints of complex microenvironments.
Fig2
Creative Biolabs leads tumor microenvironment research through extensive scientific expertise, helping partners navigate the biological complexities of the niche with unmatched technical precision and specialized knowledge.
We uniquely capture the "Epigenetic Memory" of CAFs, identifying critical therapeutic targets that remain pathologically active even after oxygen levels are fully restored.
Based on published data, our strategies targeting the CSC-CAF axis significantly reduce self-renewal capacity, offering superior performance compared to traditional monotherapy approaches.
Our high-plex approach integrates spatial biology with metabolic profiling to provide a holistic view of resistance, reducing attrition during late-stage drug development cycles.
To leverage the strategic capabilities provided by Creative Biolabs, we invite you to get a quote today.
Standard assays ignore oxygen gradients and ECM stiffness. Creative Biolabs' platform utilizes physiologic hypoxia and 3D scaffolding to mimic the "mechanical shield" of tumors, providing far more predictive data.
Yes, we highly encourage the use of specific research materials. We have established protocols for the rapid expansion and integration of CSCs and CAFs into our co-culture systems.
Quantify topographical relationships between stem cells and immune infiltrates, identifying exclusion zones and paracrine barriers that perhaps impede the efficacy of localized research therapies.
Learn More →Identify biochemical pathways within organelles using advanced imaging and isotope tracing, providing a geographical understanding of metabolic compartmentalization that perhaps drives subcellular therapy resistance.
Learn More →Creative Biolabs' CSC-Hypoxia/CAF interaction profiling service is the definitive solution for researchers seeking to dismantle the most resilient niches. By combining deep expertise with cutting-edge 3D modeling and spatial omics, we help you identify the targets that truly matter. To learn more about our profiling capabilities or to request a customized project proposal, please contact us.
Reference